Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: TAK, PITALRE, CTK1, CDC2L4, C-2k
Anti-CDK9 Monoclonal Antibody
(4V489)

| Description | Anti-CDK9 Monoclonal Antibody (4V489) is a Mouse antibody targeting CDK9. Anti-CDK9 Monoclonal Antibody (4V489) can be used in WB,IHC. |
| Synonyms | TAK, PITALRE, CTK1, CDC2L4, C-2k |
| Ig Type | IgG1 |
| Clone | 4V489 |
| Reactivity | Human |
| Application | |
| Recommended Dose | WB: 1/500-1/2000; IHC: 1/200-1/1000 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | Hybridoma Monoclonal Antibody |
| Purification | Purified by protein A or protein G |
| Appearance | Liquid |
| Formulation | Ascitic fluid containing 0.03% sodium azide |
| Concentration | 1 mg/ml |
| Research Background | The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and known as important cell cycle regulators. This kinase was found to be a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. This protein forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K. HIV-1 Tat protein was found to interact with this protein and cyclin T, which suggested a possible involvement of this protein in AIDS. (provided by RefSeq)Tissue specificity: Ubiquitous. |
| Conjucates | Unconjugated |
| Immunogen | Purified recombinant fragment of human CDK9 expressed in E. Coli. |
| Antigen Species | Human |
| Gene Name | CDK9 |
| Gene ID | |
| Protein Name | Cyclin-dependent kinase 9 |
| Uniprot ID |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.